Cresud authorized to offer 43,735,429 option shares
Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria reports that Argentina’s securities regulator has authorized the public offering of 43,735,429 ordinary shares for the future exercise of options previously approved in 2021.
Rhea-AI Filing Summary
Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria reports that Argentina’s securities regulator has authorized the public offering of 43,735,429 ordinary shares for the future exercise of options previously approved in 2021. These shares have a nominal value of ARS 1 and carry one vote each.
This new authorization is added to the remaining balance of 32,900,367 ordinary shares from the original 90,000,000-share program tied to option exercises. Current share capital is 648,742,437 shares, and it will rise to 725,378,233 shares if all outstanding options and warrants are fully exercised.
Positive
- None.
Negative
- None.
Insights
New CNV authorization ensures Cresud can honor all outstanding options.
Cresud obtained Argentine Securities Commission approval to publicly offer 43,735,429 ordinary shares linked to its existing option program. This follows the earlier authorization for 90,000,000 shares and 90,000,000 options tied to the capital increase framework set in 2019 and 2021.
The filing clarifies capital evolution: current capital is 648,742,437 shares, with 49,708,631 warrants outstanding. If every option is exercised, authorized capital for public offering will reach 725,378,233 shares, matching ARS 725,378,233 in nominal value.
The main effect is administrative alignment between option terms and available authorized shares, rather than a new discretionary issuance. Actual dilution depends on holders choosing to exercise options and warrants over time, consistent with the pre-existing program.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Cresud (CRESY) announce in this Form 6-K?
How many Cresud warrants or options remain outstanding under this program?
What will Cresud’s capital look like after the 2021 and 2026 authorizations if fully used?
AI-generated analysis. How Rhea-AI works. Not financial advice.